Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of 13-valent Pneumococcal Conjugate Vaccine Effectiveness Among People With HIV in the United States

NCT05794191 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05794191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05794191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of 13-valent Pneumococcal Conjugate Vaccine Effectiveness Among People With HIV in the United States
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
March 22, 2023
Completion date
August 15, 2024
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, infections, pneumococcal, pneumonia